WO2020241415A1 - Système d'évaluation de dose - Google Patents

Système d'évaluation de dose Download PDF

Info

Publication number
WO2020241415A1
WO2020241415A1 PCT/JP2020/019958 JP2020019958W WO2020241415A1 WO 2020241415 A1 WO2020241415 A1 WO 2020241415A1 JP 2020019958 W JP2020019958 W JP 2020019958W WO 2020241415 A1 WO2020241415 A1 WO 2020241415A1
Authority
WO
WIPO (PCT)
Prior art keywords
value
dose
parameter
treatment
planned
Prior art date
Application number
PCT/JP2020/019958
Other languages
English (en)
Japanese (ja)
Inventor
健蔵 佐々井
Original Assignee
住友重機械工業株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 住友重機械工業株式会社 filed Critical 住友重機械工業株式会社
Priority to JP2021522267A priority Critical patent/JPWO2020241415A1/ja
Publication of WO2020241415A1 publication Critical patent/WO2020241415A1/fr

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy

Definitions

  • the present invention relates to a dose evaluation system.
  • the dose estimation unit further acquires the first parameter planned value planned in the treatment plan prepared in advance for the first parameter and the second parameter planned value planned in the treatment plan for the second parameter.
  • the dose estimated value may be acquired based on the first parameter planned value, the first parameter actual value, the second parameter planned value, and the second parameter actual value.
  • Dosage dose estimate J1 ⁇ ( ⁇ (R1 ⁇ R2) / ⁇ (P1 ⁇ P2)) + J2 ⁇ ( ⁇ R1 / ⁇ P1)... Equation (1)
  • ⁇ (R1 and R2) is the value obtained by integrating the product of the actual value of the first parameter and the actual value of the second parameter from the treatment start time to the treatment end time.
  • ⁇ (P1 and P2) is the time-integrated value of the product of the first parameter planned value and the second parameter planned value from the treatment start time to the treatment end time.
  • ⁇ R1 is the value obtained by integrating the actual value of the first parameter from the treatment start time to the treatment end time.
  • ⁇ P1 is a value obtained by integrating the first parameter planned value from the treatment start time to the treatment end time.
  • upstream and downstream mean upstream (accelerator side) and downstream (patient side) of the emitted charged particle beam and neutron beam, respectively.
  • the boron neutron capture therapy system 1 shown in FIG. 1 is a device for performing cancer treatment using boron neutron capture therapy (BNCT: BoronNCT), and is a patient (irradiated subject) 40 to which boron 10 ( 10 B) has been administered. Is irradiated with neutron beam N.
  • the boron neutron capture therapy system 1 includes an accelerator 10 (eg, a cyclotron), which accelerates a charged particle (eg, a proton) to produce and emit a charged particle beam P (eg, a proton beam).
  • the target T is irradiated with a charged particle beam P to generate a neutron beam N.
  • the target T here is formed of, for example, beryllium (Be) and has a disk shape having a diameter of 160 mm.
  • the type of the target T is set according to the energy of the charged particle beam P of the accelerator 10.
  • the moderator 50 decelerates the neutron beam N emitted from the target T and reduces the energy so as to be suitable for treatment.
  • the moderator 50 has, for example, a laminated structure made of a plurality of different materials.
  • the material of the moderator 50 is appropriately selected according to various conditions such as the energy of the charged particle beam.
  • a neutron beam N is generated when a proton beam collides with the target T, and the generated neutron beam N is decelerated by the moderator 50 and irradiated to the patient 40 through the opening 46a of the collimator 46.
  • the neutron beam N itself also damages the tumor.
  • the dose evaluation system 61 physically includes a CPU, RAM and ROM as main storage devices, auxiliary storage devices such as hard disks, input devices such as keyboards and mice as input devices, output devices such as displays, network cards, and the like. It is configured as a computer system that includes a communication module that is a data transmission / reception device of. Each function of the communication unit 61a, the calculation unit 61b, the display unit 61c, etc. included in the dose evaluation system 61 can also control the CPU by loading predetermined computer software on the hardware such as the CPU and RAM. This is achieved by operating the communication module, input device, and output device, and reading and writing data in the RAM and auxiliary storage device.
  • the control unit 57 (see FIG. 1) of the boron neutron capture therapy system 1 after the treatment receives the actual value R1 of the proton beam current actually emitted from the accelerator 10 at each time (for example, every second) during the treatment. It is stored as log data. That is, the proton beam current is measured by the current monitor 32, for example, at 1-second intervals, and the measured value from the treatment start time to the treatment end time, for example, every 1 second, is sent to the control unit 57 as an actual value R1 (first parameter actual value). Is accumulated and stored as.
  • the blood boron concentration during irradiation is assumed to decrease exponentially after the administration. It may be estimated. Further, it may be assumed that the blood boron concentration is constant throughout the irradiation of the neutron beam N.
  • the present invention can be implemented in various forms with various modifications and improvements based on the knowledge of those skilled in the art, including the above-described embodiment. It is also possible to construct a modified example by utilizing the technical matters described in the above-described embodiment. The configurations of the respective embodiments may be appropriately combined and used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

L'invention porte sur un système d'évaluation de dose qui évalue, après un traitement, une dose administrée qui est une dose administrée à une tumeur d'un patient lors du traitement par un système de thérapie par capture de neutrons par le bore, une valeur réelle R1 indiquant une valeur d'un courant de faisceau de protons réel dans le traitement exécuté et une valeur réelle R2 d'une concentration réelle de bore dans le sang dans le traitement exécuté étant acquises, et une valeur d'estimation de dose administrée étant acquise sur la base d'informations concernant les valeurs acquises.
PCT/JP2020/019958 2019-05-30 2020-05-20 Système d'évaluation de dose WO2020241415A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021522267A JPWO2020241415A1 (fr) 2019-05-30 2020-05-20

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-101555 2019-05-30
JP2019101555 2019-05-30

Publications (1)

Publication Number Publication Date
WO2020241415A1 true WO2020241415A1 (fr) 2020-12-03

Family

ID=73553747

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/019958 WO2020241415A1 (fr) 2019-05-30 2020-05-20 Système d'évaluation de dose

Country Status (2)

Country Link
JP (1) JPWO2020241415A1 (fr)
WO (1) WO2020241415A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016159107A (ja) * 2015-03-05 2016-09-05 住友重機械工業株式会社 中性子捕捉療法装置
JP2019501737A (ja) * 2016-01-15 2019-01-24 南京中硼▲聯▼康医▲療▼科技有限公司Neuboron Medtech Ltd. 中性子捕捉療法システムに用いられる放射線検出システム及びその検出方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016159107A (ja) * 2015-03-05 2016-09-05 住友重機械工業株式会社 中性子捕捉療法装置
JP2019501737A (ja) * 2016-01-15 2019-01-24 南京中硼▲聯▼康医▲療▼科技有限公司Neuboron Medtech Ltd. 中性子捕捉療法システムに用いられる放射線検出システム及びその検出方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "annex 5 Evaluation index for accelerator-type neutron irradiation system for boron neutron capture therapy", MEDICINAL MACHINERY TRIAL 0523 NO. 2, vol. 5, 23 May 2019 (2019-05-23), pages 1 - 9, XP055766537, Retrieved from the Internet <URL:https://www.pmda.go.jp/files/000229738.pdf> [retrieved on 20200713] *
MATSUMOTO, TETSUO ET AL.: "Dose measuring system for boron neutron capture therapy", NUCLEAR INSTRUMENTS AND METHODS IN PHYSICS RESEARCH SECTION A: ACCELERATORS, SPECTROMETERS, DETECTORS AND ASSOCIATED EQUIPMENT, vol. 271, no. 3, 1 September 1988 (1988-09-01), pages 662 - 670, XP055538162, DOI: 10.1016/0168-9002(88)90337-3 *

Also Published As

Publication number Publication date
JPWO2020241415A1 (fr) 2020-12-03
TW202112414A (zh) 2021-04-01

Similar Documents

Publication Publication Date Title
EP2979728B1 (fr) Dispositif de thérapie par capture neutronique
EP2600356B1 (fr) Dispositif d&#39;irradiation par un rayonnement de neutrons et procédé de commande du dispositif d&#39;irradiation par un rayonnement de neutrons
JP6565113B2 (ja) 中性子捕捉療法装置
US8586948B2 (en) Particle beam irradiation apparatus and particle beam therapy system
JP6052933B2 (ja) 中性子線検出装置及び中性子捕捉療法装置
TWI418379B (zh) 粒子束照射裝置、粒子束治療裝置及記錄資料顯示程式之記錄媒體
JP6699004B2 (ja) 中性子捕捉療法システム及び中性子捕捉療法システムの制御方法
JP5850362B2 (ja) 中性子線照射装置および当該装置の作動方法
TWI666464B (zh) 中子束檢測系統及中子束檢測系統的設定方法
TW202202195A (zh) 中子捕獲治療設備
US20230314632A1 (en) Measuring device, measuring method, measuring system, and radiation therapy system
WO2020241415A1 (fr) Système d&#39;évaluation de dose
JP7021989B2 (ja) 中性子捕捉療法システム、及び中性子線検出装置
JP7084758B2 (ja) 中性子線検出装置、及び中性子線検出装置の異常検知方法
TWI839525B (zh) 劑量評估系統
JP6532008B2 (ja) 中性子線測定用ファントム装置
JP7220403B2 (ja) 粒子線治療システム、計測粒子線ct画像生成方法、およびct画像生成プログラム
JP7083994B2 (ja) 中性子線測定装置、及び中性子線測定方法
JP2019105476A (ja) 中性子線検出装置
JP2022078886A (ja) 粒子線監視システム、粒子線監視方法および粒子線治療システム
JP2020159728A (ja) 中性子線検出装置
JP2022189531A (ja) 粒子線到達位置モニタ、粒子線治療システムおよび粒子線到達位置モニタ方法
JP2017046872A (ja) 放射線治療シミュレーション装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20812595

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021522267

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20812595

Country of ref document: EP

Kind code of ref document: A1